Source:http://linkedlifedata.com/resource/pubmed/id/19866484
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2010-1-4
|
pubmed:abstractText |
The expression of interleukin 7 receptor alpha(high) (IL-7Ralpha(high)) discriminates between activated CD25(+)CD45RO(+)CD4(+) T cells [IL-7Ralpha(high) and forkhead box P3-negative (FoxP3(-))] and regulatory T cells (IL-7Ralpha(low) and FoxP3(+)). The IL-7Ralpha(high)CD25(+)CD45RO(+)CD4(+)FoxP3(-) T cell population has been shown to be expanded in the blood and tissues of patients after kidney transplantation and to contain alloreactive T cells (activated T cells). In the present study, we analyzed the distribution of IL-7Ralpha(high)CD25(+)CD45RO(+)CD4(+)FoxP3(-) T cells in the blood of 53 patients after liver transplantation. The IL-7Ralpha(high)CD25(+)CD45RO(+)CD4(+)FoxP3(-) T cell population was significantly expanded (P < 0.0001) in stable transplant recipients versus healthy donors. However, the magnitude of the expansion was significantly higher (P < 0.0001) in liver transplant recipients with no hepatitis C virus (HCV) infection in comparison with those with a preexisting HCV infection. Interestingly, effective suppression of HCV viremia after antiviral therapy was associated with an increase in the IL-7Ralpha(high)CD25(+)CD45RO(+)CD4(+)FoxP3(-) T cell population to levels comparable to those of liver transplant recipients not infected with HCV. The present results indicate that (1) the IL-7Ralpha(high)CD25(+)CD45RO(+)CD4(+)FoxP3(-) T cell population is expanded after liver transplantation, (2) it is a valuable immunological marker for monitoring activated and potential alloreactive CD4 T cells in liver transplantation, and (3) a preexisting HCV infection negatively influences the expansion of this population in liver transplant recipients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1527-6473
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
49-55
|
pubmed:meshHeading |
pubmed-meshheading:19866484-Adult,
pubmed-meshheading:19866484-Aged,
pubmed-meshheading:19866484-Antiviral Agents,
pubmed-meshheading:19866484-Case-Control Studies,
pubmed-meshheading:19866484-Down-Regulation,
pubmed-meshheading:19866484-Female,
pubmed-meshheading:19866484-Hepatitis C, Chronic,
pubmed-meshheading:19866484-Humans,
pubmed-meshheading:19866484-Interleukin-7 Receptor alpha Subunit,
pubmed-meshheading:19866484-Liver Transplantation,
pubmed-meshheading:19866484-Male,
pubmed-meshheading:19866484-Middle Aged,
pubmed-meshheading:19866484-Postoperative Complications,
pubmed-meshheading:19866484-T-Lymphocytes, Regulatory,
pubmed-meshheading:19866484-Young Adult
|
pubmed:year |
2010
|
pubmed:articleTitle |
Hepatitis C virus infection after liver transplantation is associated with lower levels of activated CD4(+)CD25(+)CD45RO(+)IL-7ralpha(high) T cells.
|
pubmed:affiliation |
Division of Immunology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
|
pubmed:publicationType |
Journal Article
|